DULUTH, Ga., May 30 /PRNewswire/ -- Stiefel Laboratories has announced the appointment of Jim Loerop to the position of Vice President of Corporate Development. He will be responsible for identifying, negotiating and implementing commercially viable new business opportunities, acquisitions and divestitures. Loerop also will develop strategic partnerships and new business affairs that deliver innovation in the form of products, alliances, new technology or services.
“Jim is a tremendous asset to the Stiefel organization,” said Bill Humphries, Senior Vice President, Commercial Operations, Stiefel Laboratories. “Our growth will be exponentially magnified by the addition of Jim’s noteworthy corporate development expertise.”
Loerop has a thorough background in the industry. His career spans positions at Solvay Pharmaceuticals, Curatek Pharmaceuticals and IMS Health. Most recently he served as the Vice President of Corporate Development and Business Expansion at KV Pharmaceutical Co. in St. Louis, Mo.
About Stiefel Laboratories, Inc.
Founded in 1847, Stiefel Laboratories is the world’s largest independent pharmaceutical company specializing in dermatology. Its wholly owned global network is comprised of more than 30 subsidiaries including manufacturing plants in six countries, and R&D facilities on three continents. Stiefel supplements its R&D by aggressively seeking acquisitions of dermatological product lines and companies around the world. To learn more about Stiefel, visit http://www.stiefel.com.
Stiefel Laboratories
CONTACT: Erin Bacher of Ogilvy Public Relations Worldwide,+1-404-881-2324, or Erin.Bacher@ogilvypr.com, for Stiefel Laboratories
Web site: http://www.stiefel.com/
